SUNNYVALE, Calif., May 31, 2005 /PRNewswire-FirstCall via COMTEX/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) announced today that Richard A. Miller, M.D., president and chief executive officer, is scheduled to present a corporate overview at the Pacific Growth Equities 2005 Life Sciences Growth Conference at 2:30 p.m. on Monday, June 6th at the Mark Hopkins Inter-Continental Hotel in San Francisco, CA.
To access the live audio broadcast or the subsequent archived recording log on to http://www.pharmacyclics.com . The archived version of the webcast will be available on the company's website for one month.
Pharmacyclics is a pharmaceutical company developing innovative products to treat cancer and atherosclerosis. The company's products are rationally designed, ring-shaped small molecules called texaphyrins that are designed to selectively target and disrupt the bioenergetic processes of diseased cells, such as cancer and atherosclerotic plaque. More information about the company, its technology, and products in development can be found on its website at www.pharmacyclics.com. Pharmacyclics(R) and the "pentadentate" logo(R) are registered trademarks of Pharmacyclics, Inc.
SOURCE Pharmacyclics, Inc.
Leiv Lea of Pharmacyclics, Inc., +1-408-774-0330; or Carolyn Bumgardner Wang of WeissComm Partners, +1-415-946-1065, for Pharmacyclics, Inc.
Copyright (C) 2005 PR Newswire. All rights reserved.
News Provided by COMTEX